These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23322279)

  • 1. Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis.
    Pisa D; Alonso R; Jiménez-Jiménez FJ; Carrasco L
    Eur J Clin Microbiol Infect Dis; 2013 Jun; 32(6):795-801. PubMed ID: 23322279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fungal infection in a patient with multiple sclerosis.
    Pisa D; Alonso R; Carrasco L
    Eur J Clin Microbiol Infect Dis; 2011 Oct; 30(10):1173-80. PubMed ID: 21533622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of neuroparacoccidioidomycosis by detection of circulating antigen and antibody in cerebrospinal fluid.
    da Silva SH; Colombo AL; Blotta MH; Queiroz-Telles F; Lopes JD; de Camargo ZP
    J Clin Microbiol; 2005 Sep; 43(9):4680-3. PubMed ID: 16145126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis and mixed microbial infections. Direct identification of fungi and bacteria in nervous tissue.
    Alonso R; Fernández-Fernández AM; Pisa D; Carrasco L
    Neurobiol Dis; 2018 Sep; 117():42-61. PubMed ID: 29859870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between multiple sclerosis and Candida species: evidence from a case-control study.
    Benito-León J; Pisa D; Alonso R; Calleja P; Díaz-Sánchez M; Carrasco L
    Eur J Clin Microbiol Infect Dis; 2010 Sep; 29(9):1139-45. PubMed ID: 20556470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for fungal infection in cerebrospinal fluid and brain tissue from patients with amyotrophic lateral sclerosis.
    Alonso R; Pisa D; Marina AI; Morato E; Rábano A; Rodal I; Carrasco L
    Int J Biol Sci; 2015; 11(5):546-58. PubMed ID: 25892962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of antibody response and fungal antigens in the serum of a patient infected with Candida famata.
    Pisa D; Ramos M; Molina S; García P; Carrasco L
    J Med Microbiol; 2007 May; 56(Pt 5):571-578. PubMed ID: 17446276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.
    Warren KG; Catz I
    Eur Neurol; 1999; 42(2):95-104. PubMed ID: 10473981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis and neurological controls.
    Sotgiu S; Piana A; Pugliatti M; Sotgiu A; Deiana GA; Sgaramella E; Muresu E; Rosati G
    Mult Scler; 2001 Dec; 7(6):371-4. PubMed ID: 11795458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.
    Doronin VB; Parkhomenko TA; Castellazzi M; Cesnik E; Buneva VN; Granieri E; Nevinsky GA
    PLoS One; 2016; 11(5):e0154688. PubMed ID: 27196086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human spumaretrovirus antibody reactivity in multiple sclerosis.
    Lycke J; Svennerholm B; Svenningsson A; Muranyi W; Flügel RM; Andersen O
    J Neurol; 1994 Feb; 241(4):204-9. PubMed ID: 8195818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble HLA class I and class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patients.
    Filaci G; Contini P; Brenci S; Gazzola P; Lanza L; Scudeletti M; Indiveri F; Mancardi GL; Puppo F
    Hum Immunol; 1997 Apr; 54(1):54-62. PubMed ID: 9154458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis.
    Fialová L; Bartos A; Svarcová J; Zimova D; Kotoucova J; Malbohan I
    J Neuroimmunol; 2013 Sep; 262(1-2):113-20. PubMed ID: 23870535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungal infection in patients with serpiginous choroiditis or acute zonal occult outer retinopathy.
    Pisa D; Ramos M; García P; Escoto R; Barraquer R; Molina S; Carrasco L
    J Clin Microbiol; 2008 Jan; 46(1):130-5. PubMed ID: 18003800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.
    Beseler C; Vollmer T; Graner M; Yu X
    PLoS One; 2017; 12(10):e0186842. PubMed ID: 29059249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
    Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
    J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid and serum levels of interleukin-8 in patients with multiple sclerosis and its correlation with Q-albumin.
    Matejčíková Z; Mareš J; Sládková V; Svrčinová T; Vysloužilová J; Zapletalová J; Kaňovský P
    Mult Scler Relat Disord; 2017 May; 14():12-15. PubMed ID: 28619424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases.
    Kušnierová P; Zeman D; Hradílek P; Zapletalová O; Stejskal D
    PLoS One; 2020; 15(5):e0233519. PubMed ID: 32437412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
    Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
    PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.